• Do depression rates differ by conflict era among War Veterans?

    May 1, 2015, 00:00

  • An Indirect Comparison of Iwqol-Lite total Score Change In Subjects treated with Canagliflozin, Exenatide qw, Sitagliptin, or Pioglitazone In dual Therapy With Background Metformin

    May 1, 2015, 00:00

  • Use of Abiraterone in The Management of Castration-Resistant Prostate Cancer- a Real-Life Cost-Effectiveness Study

    May 1, 2015, 00:00

  • Variations in primary treatment among Elderly Women with early stage Breast Cancer- associations with factors related to old age and Vulnerable Socio-Demographics

    May 1, 2015, 00:00

  • FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

    May 1, 2015, 00:00

  • Metastatic-Free Survival And Overall Survival In Prostate Cancer

    May 1, 2015, 00:00

  • Factors Affecting 30-Day Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (Copd)

    May 1, 2015, 00:00

  • Annual Hospitalization Frequency For Patients With Heart Failure - A Comparison Between Commercial And Medicare Advantage Population

    May 1, 2015, 00:00

  • Sex Differences In over-the-counter sleep aid use in older adults

    May 1, 2015, 00:00

  • Bone Pain, Skeletal Related Events and Opioid Use in Patients With Prostate Cancer And Bone Metastases

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Condoliase In Patients With Lumbar Disc Herniation In Japan

    May 1, 2015, 00:00

  • Assessment of Disease State Knowledge Among Tb Patients In Quetta, Pakistan

    May 1, 2015, 00:00

  • Predictors of Allopurinol adherence in patients with Gout

    May 1, 2015, 00:00

  • Cost-Effectiveness of Co-Administered Branded Therapies In Oncology- Pricing Insights From an Early Economic Model

    May 1, 2015, 00:00

  • Prospective Benefit-Risk Monitoring Of New Drugs For Rapid Assessment Of Net Favorability In Electronic Healthcare Data

    May 1, 2015, 00:00

  • Clopidogrel Versus Aspirin In Patients With Atherothrombosis- A Caprie-Based Economic Analysis In A Health Resource Limited Setting

    May 1, 2015, 00:00

  • Pharmacotherapy Optimization plan for patients with type-2 Diabetes mellitus (T2DM) and Hypertension in a Chilean Healthcare setting- impact and outcomes

    May 1, 2015, 00:00

  • A Necessary convergence? US payers adopting EU Behaviors

    May 1, 2015, 00:00

  • Conditional Survival Probabilities for Previously Untreated Advanced Melanoma Patients Receiving Ipilimumab- Model Based Analysis

    May 1, 2015, 00:00

  • Office-based uterine polypectomy using a minimally invasive Hysteroscopic tissue removal device saves Healthcare resources

    May 1, 2015, 00:00

  • Diffusion of Ultrasound among Physicians treating patients with Rheumatoid Arthritis- 2002-2013

    May 1, 2015, 00:00

  • Validation of Prescription Medication Adherence prediction Tool (Rxapt) to Predict non-Adherence among Diabetes Patients Enrolled in medicare

    May 1, 2015, 00:00

  • Investigation Of Relationships Between Biomarkers Of Potential Harm And Cigarette Smoking Measures Among Current, Past, And Non-Smokers Based On National Health And Nutrition Examination Survey 2007-2012

    May 1, 2015, 00:00

  • Comparison Of Machine Learning, Statistical And Hybrid Methods To Identify Predictors Of Positive Treatment Outcomes In Comorbid Conditions Using Emr Data

    May 1, 2015, 00:00

  • Emergency disease Spectrum in China- based on Hospital database from Beijing

    May 1, 2015, 00:00

  • Impact Of Single Risk Factor Changes On Long-Term Outcomes And Cost In A Type 2 Diabetes Modeling Study Contrasting Projections With Ukpds68, Swedish National Diabetes Registry And The Advance Risk Equations

    May 1, 2015, 00:00

  • The Use Of Statins Among Prior-Users After Hemodialysis

    May 1, 2015, 00:00

  • Assessing the availability of Drugs marketed in the US and Switzerland

    May 1, 2015, 00:00

  • A retrospective analysis of health care resource utilization and the economic burden among u.s. Long-term care facility patients diagnosed with stroke

    May 1, 2015, 00:00

  • Increased rates of self monitoring of Blood Glucose translates to better marginal effects on HBA1C Control

    May 1, 2015, 00:00

  • Adherence and persistence to anti-epileptic drugs among u.s. Veterans diagnosed with epilepsy

    May 1, 2015, 00:00

  • Is there an impact of the Orphan designation in Oncology on market access in Europe?

    May 1, 2015, 00:00

  • Time-dependence of first appropriate Therapy in primary prevention implantable cardioverter defibrillator patients- is device replacement necessary in patients without prior ICD interventions?

    May 1, 2015, 00:00

  • Pharmacoeconomic evaluation of Glp-1 Receptors Agonist Versus Dpp-4 Inhibitors In patients with Type 2 Diabetes-A systematic review

    May 1, 2015, 00:00

  • Specialty tier cost sharing and use of disease modifying Therapies Among Medicare Beneficiaries with Multiple Sclerosis

    May 1, 2015, 00:00

  • Comparative effectiveness of Fibrin sealants in Cardiac Surgery

    May 1, 2015, 00:00

  • Modelling The Clinical And Economic Outcomes Of Variations In Intensity Of Valsartan-Centric Regimens For Hypertension

    May 1, 2015, 00:00

  • Understanding the average svr rates of hepatitis c treatments and their implications on clinical and economic outcomes- then vs. Now

    May 1, 2015, 00:00

  • Literature review of the use of ICER thresholds in Healthcare decision-making

    May 1, 2015, 00:00

  • Increasing Households’ Access To Healthcare; Linking Clinicians To Community Health Workers Through Counter Referral Comments

    May 1, 2015, 00:00

  • Cachexia debility in Hospitalized Children with complex Chronic conditions

    May 1, 2015, 00:00

  • The validity of the Proportional Hazards assumption for the meta-analysis of time to event data to support submissions to Health Technology Assessment (HTA) authorities

    May 1, 2015, 00:00

  • Patients In The Waiting List Of Bariatric Surgery In The Brazilian Public Sector Treatment Patterns And Health Outcomes- A Non-Interventional Single-Site Retrospective Study

    May 1, 2015, 00:00

  • Cost – Efficacy Study for Ipilimumab in the Chilean Market

    May 1, 2015, 00:00

  • Trend analysis of G-BA decisions – what factors influence the Likelihood of recommendations?

    May 1, 2015, 00:00

  • Impact of tolerability profiles on HTA decision making in Oncology

    May 1, 2015, 00:00

  • Tackling the tariff for Sofosbuvir In hcv – Indispensable Innovation Versus Budget-Busting Potential

    May 1, 2015, 00:00

  • Point-of-care, real-time decision support tools- a pathway compliance solution but only when they are used

    May 1, 2015, 00:00

  • Description of Patients satisfaction or dissatisfaction with referral and counter referral process

    May 1, 2015, 00:00

  • Gender-specific safety outcome reports for New Molecular entity Drugs

    May 1, 2015, 00:00

  • Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States

    May 1, 2015, 00:00

  • Impact of Patient reported outcomes on Medication Therapy Management for High-Cost Specialty Drugs

    May 1, 2015, 00:00

  • Hospital Utilization In Patients With Ebstein’s Anomaly

    May 1, 2015, 00:00

  • Predictors of Cigarette Smoking in Three Asian Countries- China India and Taiwan

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

    May 1, 2015, 00:00

  • Data Extraction For Systematic Review – Where To Look For Data Outside The Primary Publication

    May 1, 2015, 00:00

  • Characteristics of Combination Pharmacotherapy in Patients with Diabetic Painful Neuropathy (DPN)

    May 1, 2015, 00:00

  • Will flat EU Pricing become a reality? considerations for the Biopharma industry and whether future EU pricing transparency rules will affect the Current position

    May 1, 2015, 00:00

  • Modelling The Cost Determinants For Older Persons’ Transitions In Care (Optic)

    May 1, 2015, 00:00

  • Evidence of a gap in care- utilization of Radiologic Diagnostic imaging in patients with and without implantable defibrillators

    May 1, 2015, 00:00

  • Direct medical costs associated with Clinical and Health characteristics in visually impaired individuals in Singapore

    May 1, 2015, 00:00

  • A Review of Methodologies used to assess adherence to Disease Modifying Therapies among Patients with Multiple Sclerosis

    May 1, 2015, 00:00

  • Relationship of Serum Uric Acid Levels With Hypertension And Hyperlipidemia In Patients With Gout

    May 1, 2015, 00:00

  • Modeling of Societal Costs Under Different Treatment Schemes of Post-Stroke Spasticity In The Russian Federation

    May 1, 2015, 00:00

  • Treatment outcomes of Smear Positive Pulmonary TB Cases Registered In TB Patients In Quetta

    May 1, 2015, 00:00

  • A Systematic Quantitative Approach To Incorporating The Patient Perspective Into Health Technology Assessment Decision Making

    May 1, 2015, 00:00

  • Healthcare Resource utilization and Medical Care Cost Associated With New Bio-Surgical Hemostasis In China

    May 1, 2015, 00:00

  • MEDICATION COST IMPLICATION FOR THE MANAGEMENT OF HYPERTENSION AND DIABETES IN NIGER DELTA- TERTIARY HOSPITAL BASED STUDY IN BAYELSA STATE, NIGERIA

    May 1, 2015, 00:00

  • Geographic Differences In Availability Of Antihypertensive Medications- A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The Us

    May 1, 2015, 00:00

  • Benzodiazepine usage Patterns in respondents with Depression from the Co-Morbidities and Symptoms of Depression (CODE) study

    May 1, 2015, 00:00

  • Effect of Patient’s cost sharing on Expenditures- an Instrumental Variables Approach

    May 1, 2015, 00:00

  • Venous Thromboembolism Prevalence In French And Us Hospitals- Comparison On The Basis Of The National Data Bases

    May 1, 2015, 00:00

  • Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada

    May 1, 2015, 00:00

  • Initiation and evaluation of Clinical Pharmacy Services to Surgical Ward in a South Indian tertiary care Teaching Hospital

    May 1, 2015, 00:00

  • Budget impact and cost- effectiveness of an innovative Blood glucose measurement device using pattern alert technology in insulin-treated diabetics in the United States

    May 1, 2015, 00:00

  • Contextual analysis of determinants of late Diagnosis of Hepatitis C Virus infection in medicare patients

    May 1, 2015, 00:00

  • Impact Of Enzalutamide or Abiraterone Acetate + Prednisone (Abp) on Quality Of Life (Qol) In The Treatment of Metastatic Castration-Resistant Prostate Cancer (mcrpc) That Has Progressed on Or After Doxetaxel- A Comparative Effectiveness Stu ...

    May 1, 2015, 00:00

  • Defining uncontrolled diabetes from the patient Perspective- A four-country study in People with type-2 Diabetes On Basal Insulin

    May 1, 2015, 00:00

  • Influence of Patient-Reported outcomes on Regulatory, Hta and Market access decisions- obesity and diabetes case Examples

    May 1, 2015, 00:00

  • Improved Health Care outcomes and Cost Savings for Asthma Through Targeted Home Interventions

    May 1, 2015, 00:00

  • The impact of Genomic testing on Chemotherapy use and medical spending in a commercially-insured population of Breast Cancer Patients

    May 1, 2015, 00:00

  • Bayesian Hierarchical modeling of randomized and non-randomized studies comparing ciclosporin with immediate- and prolonged-release tacrolimus in Liver Transplant Recipients

    May 1, 2015, 00:00

  • Baseline Demographics And Clinical Characteristics Associated With Healthcare Costs Among Patients With Atherosclerotic Cardiovascular Disease

    May 1, 2015, 00:00

  • Real-world treatment patterns of antihyperglycemic agents among patients with type 2 diabetes melltus (T2dm) Initiated on canagliflozin

    May 1, 2015, 00:00

  • Health resource use and cost analysis of Schizophrenia patients participating in a Randomized, Multicenter, Double-Blind, relapse prevention study of paliperidone palmitate 3-month formulation

    May 1, 2015, 00:00

  • The Use Of Bootstrap Model Averaging When Estimating Survival Curves

    May 1, 2015, 00:00

  • Association Between Bone Mineral Density and type 1 Diabetes Mellitus- A meta-Analysis of Observational Studies

    May 1, 2015, 00:00

  • Forecasting the United States Lifetime Cost and outcomes of Ivacaftor in Patients with Cystic Fibrosis

    May 1, 2015, 00:00

  • Administration Cost Of Pediatric Vaccination- A Focused Literature Review

    May 1, 2015, 00:00

  • A Survey of ispor attendee views on the use of ICER and acceptable ICER thresholds

    May 1, 2015, 00:00

  • Economics in clinical guidelines- a cost-effectiveness analysis of repositioning strategies for the prevention of pressure Ulcers

    May 1, 2015, 00:00

  • Patient Registries In India – National Cancer Registry Program

    May 1, 2015, 00:00

  • Trends in antihypertensive medication use in us office-based practices- are elderly patients treated diffrerently?

    May 1, 2015, 00:00

  • The Expected Impact of Oncology Biosimilars In Brazil And Mexico- Payers and Oncologists Consider The cost-Effectiveness of These Cheaper Alternatives

    May 1, 2015, 00:00

  • A Model to explore the potential budget impact of a novel screening tool for the detection of subclinical rejection among Kidney Transplant Patients

    May 1, 2015, 00:00

  • Cost Effectiveness Of Statins In Primary Prevention Of Coronary Heart Disease- A Systematic Review And Quality Assessment Of Economic Evidence To Elucidate Recent Trends In Usa

    May 1, 2015, 00:00

  • Cost Minimization Analysis Of Immunosuppressive Treatment On Kidney Transplant Patients

    May 1, 2015, 00:00

  • All-cause 30-day readmissions among medicaid beneficiaries with selected Chronic conditions- a multi-level analysis

    May 1, 2015, 00:00

  • Bone Safety Profile of Denosumab Therapy- a Pharmacovigilance Characterization Analysis

    May 1, 2015, 00:00

  • “Would You Like An All-Inclusive Luxury Holiday With First Class Flights To Egypt With Your Sovaldi Prescription” - Innovative Cost-Saving Solutions For Us Payers

    May 1, 2015, 00:00

  • Projected Cost Savings of Introducing fecal Microbiota Transplant Treatment for Clostridium Difficile Infection In Canada

    May 1, 2015, 00:00

  • Systematic review with Qualitative Assessment of Antidepressant Monotherapies in Patients with Major depressive Disorder with an inadequate response to a prior SSRI or SNRI

    May 1, 2015, 00:00

  • Use of infliximab within a Patient support program- positive perception of iv Infusions from Patients’ perspective

    May 1, 2015, 00:00

  • Common Chronic Conditions, Disability And Perceived Health- Empirical Support Of A Conceptual Model

    May 1, 2015, 00:00

  • Assessment Of Treatment Adherence And Quality Of Life In Diabetic Patients Treated With Insulin In Two Colombian Cities

    May 1, 2015, 00:00

  • Factors Predicting Receipt of Prostate Specific Antigen (PSA) Testing- Evidence from the national ambulatory Medical Care Survey (Namcs) data

    May 1, 2015, 00:00

  • Measurement properties of Web based Lupuspro, a disease targeted Otcome Tool, among Italian Patients with Lupus

    May 1, 2015, 00:00

  • Coverage of Medical devices- is Medicare consistent with Private Payers?

    May 1, 2015, 00:00

  • Psychometric Validation Of The Fatigue Symptoms And Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmsâ„¢)

    May 1, 2015, 00:00

  • Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey

    May 1, 2015, 00:00

  • The Rationale Of Early Prescription Of Antibiotics In Organophosphorus Poisoning Patients

    May 1, 2015, 00:00

  • Current treatment patterns and survival in relapsed or refractory multiple Myeloma- findings from a brief survey of European Physicians

    May 1, 2015, 00:00

  • Trend analysis of Technology appraisal decisions from the National Institute of Health and Care Excellence (NICE) – what factors influence the likelihood of recommendations?

    May 1, 2015, 00:00

  • Use of Anti-osteoporosis Medications and Fracture Risk Among Elderly Patients With End-Stage Renal Disease- A Retrospective Cohort Study

    May 1, 2015, 00:00

  • Possibilities Of Childhood Vaccinations

    May 1, 2015, 00:00

  • Switching In Part D Prescription Plan- Plan Switching Versus Brand Name Drug Switching

    May 1, 2015, 00:00

  • Examining prevalence, incidence and mortality rates among opioid-dependent patients in the U.S. Medicare Population

    May 1, 2015, 00:00

  • Use of consumer market research panels to generate prevalence and disease burden estimates in data-sparse diseases- a case study in severe Chronic Hand Eczema

    May 1, 2015, 00:00

  • The Incremental Cost Of Reoperations For Bleeding Events In Cardiac And Vascular Reconstructive Surgery

    May 1, 2015, 00:00

  • Development Of Electronic Diary In Patients With Primary Biliary Cirrhosis

    May 1, 2015, 00:00

  • A NEW METHOD FOR COUNTING HEMOPHILIA-RELATED BLEEDING EVENTS IN CLAIMS DATA

    May 1, 2015, 00:00

  • Impact of Young-onset Parkinson’s Disease on Quality of Life €“ a Literature Review

    May 1, 2015, 00:00

  • Quality of Life of Patients With Parkinson’s Disease And Other Neurodegenerative Disorders

    May 1, 2015, 00:00

  • Assessment Of Nephrotoxicity And Cost Implications Of Colistin Therapy In Icu Patients

    May 1, 2015, 00:00

  • The Effectiveness of Carepak® Adherence Packaging In Increasing Lenalidomide Therapy Duration

    May 1, 2015, 00:00

  • Classification Tree Analysis Of The Likelihood Of Clopidogrel Treatment In A Cohort Of Patients With Symptomatic Peripheral Artery Disease

    May 1, 2015, 00:00

  • Alemtuzumab Budget Impact Analysis in Relapsing-Remitting Multiple Sclerosis in the US

    May 1, 2015, 00:00

  • Specialty Pharmacy Medication compliance and persistence program for patients with Pulmonary Arterial Hypertension

    May 1, 2015, 00:00

  • Real-world canagliflozin utilization- Impact on glycemic control in Patients with Type 2 diabetes mellitus

    May 1, 2015, 00:00

  • The Effect of ras-Modifying Medications on Pulmonary Health In Patients with Type 2 Diabetes mellitus

    May 1, 2015, 00:00

  • A DESCRIPTIVE ANALYSIS OF TIME TO FIRST TREATMENT WITH DISEASE-MODIFYING DRUGS (DMDS) IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE SCLEROSIS (MS)

    May 1, 2015, 00:00

  • Relation between Health Insurance coverage and outcomes among women with Breast Cancer in Florida

    May 1, 2015, 00:00

  • Which diseases are driving the Increase in spending for the Privately Insured Population of the US?

    May 1, 2015, 00:00

  • Evaluation of the Quality of Life of Diabetic Patients in Minas Gerais State, Brazil

    May 1, 2015, 00:00

  • Healthcare Resource Utilization associated with dalfampridine Extended Release In Multiple Sclerosis- A Retrospective Claims Database Analysis

    May 1, 2015, 00:00

  • Preventing Cervix-Uterus Cancer in Argentina. Structrure, Organization and Results

    May 1, 2015, 00:00

  • Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In Colombia

    May 1, 2015, 00:00

  • Eliciting Patient Treatment Preferences- Development Of A Methodological Framework For Attribute Identification And Validation For Discrete Choice Experiments

    May 1, 2015, 00:00

  • The Impact of Negative Trial Results on The Use of Blood Transfusions

    May 1, 2015, 00:00

  • Anti-Diabetic Drugs and the risk of Dementia Among Medicare Beneficiaries with diabetes

    May 1, 2015, 00:00

  • Impact Of The Patient Protection And Affordable Care Act Contraceptive Coverage Mandate On Utilization Of Refillable And Long-Acting Reversible Contraceptives

    May 1, 2015, 00:00

  • Developing Hospital Based Hta For Egyptian Cancer Patients

    May 1, 2015, 00:00

  • Knowledge And Awareness Of Oral Cancer In Guntur Area,South India

    May 1, 2015, 00:00

  • Prevalence And Predictors Of Health Risk Behaviors In Undergraduate Health Sciences Students Of Khyber Medical University

    May 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes on Market Access Decisions In Decentralized Markets (Brazil, Italy, Spain, and the United States)

    May 1, 2015, 00:00

  • Bayesian network Meta-Analysis (Nma) to Assess the relative Efficacy of Canagliflozin Monotherapy over 26 weeks In Patients with Type 2 Diabetes mellitus (T2dm)

    May 1, 2015, 00:00

  • The changing costs of caring for Hemophilia Patients in the U.S.- insurers’ and patients’ perspectives

    May 1, 2015, 00:00

  • Development and Content Validity Testing of The Patient-Reported Outcomes of Fatigue In Cancer (Proof-C) Symptom Severity Assessment (Ssa)

    May 1, 2015, 00:00

  • The concentration of Antipsychotic prescribing- Evidence from Medicaid

    May 1, 2015, 00:00

  • Overview and importance of nub process for Market Access of in-patient Drugs and devices in Germany

    May 1, 2015, 00:00

  • Tree-Based Claims Algorithm For Measuring Pre-Treatment Quality Of Care In Medicare Disabled Hepatitis C Patients

    May 1, 2015, 00:00

  • A Cost-effectiveness analysis of Antipsychotics for treatment of Schizophrenia in Uganda

    May 1, 2015, 00:00

  • Efficiency analysis of the Hungarian outpatient-care system with data envelopment analysis

    May 1, 2015, 00:00

  • Predicting Phase Iii Survival outcomes Using Phase Ii Trial Data In Nsclc and Rcc

    May 1, 2015, 00:00

  • Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

    May 1, 2015, 00:00

  • Evaluation of Audit scoring Consistency in a comprehensive feedlot Management System and correlation with feedyard performance based on average daily Gain and Dry feed conversion in 11 US feedlots

    May 1, 2015, 00:00

  • The Impact Of Parents’ Knowledge And Practice On Their Children Immunization Timeliness- Experience From Malaysia

    May 1, 2015, 00:00

  • Timing of eu5 US Orphan Drug approvals and PRMA between 2009 and 2013

    May 1, 2015, 00:00

  • Proton Pump inhibitor prescribing trend in the us Ambulatory setting

    May 1, 2015, 00:00

  • Assessing the economic burden of u.s. Medicare patients diagnosed with non-hodgkin’s lymphoma

    May 1, 2015, 00:00

  • Comparing Diagnosis-Based And Prescription-Based Comorbidity Measures For Predicting Health Service Utilization And Costs

    May 1, 2015, 00:00

  • The Electronic Age- Integrating Epro/Ecoa To Reduce Patient, Site, And Study Team Burden

    May 1, 2015, 00:00

  • Life At A Premium- Considering An End-Of-Life Premium In Value-Based Reimbursement

    May 1, 2015, 00:00

  • Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaid

    May 1, 2015, 00:00

  • Do pharmacists’ Barriers—including non-reimbursement for non-dispensing services—influence the level of adherence promotion activities for persons Living with HIV?

    May 1, 2015, 00:00

  • Loss of Productivity Costs Attributable to Being overweight or Obese In Working Asthma Patients In The Us

    May 1, 2015, 00:00

  • Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia Patients

    May 1, 2015, 00:00

  • Availability and Use of Epinephrine Auto-Injectors for The Treatment of Anaphylaxis- Results From The Epipen4schoolsâ® Survey

    May 1, 2015, 00:00

  • Assessing the economic burden and health care resource utilizations of u.s. Medicare patients with myeloproliferative neoplasms

    May 1, 2015, 00:00

  • Current Situation Of The Public-Private Partnerships For Drugs In Brazil

    May 1, 2015, 00:00

  • Assessment Of Level Of Medication Adherence In Different Non-Communicable Chronic Diseases Patient In Quetta, Pakistan- Dose Disease Condition Produces Any Change

    May 1, 2015, 00:00

  • Peripheral arterial disease management program- screening-risk factor management program and financial return on investment

    May 1, 2015, 00:00

  • Patients’ perception and Knowledge of adverse Drug reactions associated with Herbal Medicines

    May 1, 2015, 00:00

  • Estimating the cost of Pneumonia cases admitted at the internal medicine wards of a tertiary Government Hospital in the Philippines

    May 1, 2015, 00:00

  • Out-of-pocket Healthcare Expenditures among patients with Chronic obstructive Pulmonary disease

    May 1, 2015, 00:00

  • Cost-Minimization analysis of Infliximab versus Adalimumab in the treatment of Crohn’s disease and Ulcerative Colitis

    May 1, 2015, 00:00

  • What type of response scale is the most responsive? A comprehensive review of response scale options for patient-reported outcome measures

    May 1, 2015, 00:00

  • Efficacy and Safety of Insulin Analogues Compared to Human Insulin Preparations for the treatment of Patients With Diabetes Type 1 (Dm1)- Systematic Review and Meta-Analysis

    May 1, 2015, 00:00

  • Patient- and Physician-Reported Motivations for Medication Non-Adherence or Switching In Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in treatment-naÏve adults with Genotype 1B (GT1B) Chronic Hepatitis C

    May 1, 2015, 00:00

  • Impact of a Pharmacist telephone Intervention on Preventing Medication discontinuation among Hypertensive Patients With Diabetes In a Medicare advantage plan

    May 1, 2015, 00:00

  • Patterns of Disease Remission Among Patients With Rheumatoid Arthritis Treated With Biologic Therapies In Japan

    May 1, 2015, 00:00

  • Effects of Overweight and Obesity on Health service use and expenditures among U.S. adults with Chronic renal disease

    May 1, 2015, 00:00

  • Comparative Efficacy of Interventions for Overactive Bladder Syndrome- A Systematic Review And Network Meta-Analysis

    May 1, 2015, 00:00

  • Contrasting Cost-Effectiveness Results Derived From Contemporary Sets Of Alternative Risk Equations In Type 2 Diabetes

    May 1, 2015, 00:00

  • A Review of Patient-Reported Outcomes (pros) in Patients with Cutaneous Lupus Erythematosus (CLE)

    May 1, 2015, 00:00

  • CRITICAL PROBLEMS OF CODING DATA IN HEALTH CARE- OBESITY, SMOKING, AND ALCOHOL USE BY METHOD OF MEASUREMENT

    May 1, 2015, 00:00

  • Characteristics of Patients with Systemic Lupus Erythematosus (SLE) currently experiencing flares in clinical practice settings in Europe (EU)

    May 1, 2015, 00:00

  • Cost Effectiveness Analysis Of Apixaban Compared To Oral Anticoagulants In The Prevention Of Thromboembolic Events In Patients With Non-Valvular Atrial Fibrillation In Guatemala In 2014

    May 1, 2015, 00:00

  • Application Of Difference-In-Difference Methodology In Comparative Effectiveness Research With Unbalanced Groups

    May 1, 2015, 00:00

  • Economic impact of using Harmonic Scalpel Technology in Surgery

    May 1, 2015, 00:00

  • The value of non-randomised evidence for informing Clinical effectiveness- an assessment of HTA requirements and Published Guidance regarding the appropriateness of non-randomised data

    May 1, 2015, 00:00

  • Aprotinin free Hemostatic sealant to reduce Blood loss in Surgical Patients- a systematic review

    May 1, 2015, 00:00

  • Cost per additional responder associated with Biologic use in Psoriasis

    May 1, 2015, 00:00

  • Cross-state comparison of medicaid Anti-Obesity medication coverage- 1999-2013

    May 1, 2015, 00:00

  • Federal exchanges provide Lower Premiums but Less Generous Pharmacy benefits than Employer-Sponsored Plans

    May 1, 2015, 00:00

  • Changes In Baseline Comorbidities, Medications And Healthcare Costs for A Population of Patients With New-Onset Type 2 Diabetes (T2d) In 2007 Compared With 2012

    May 1, 2015, 00:00

  • Unmet needs and treatment patterns in Lupus- results from an online Community

    May 1, 2015, 00:00

  • Building quality in hta process and decision making- can key performance measures of good practices in hta be identified?

    May 1, 2015, 00:00

  • Direct Medical Costs Of Her2 Positive Breast Cancer Management In Iran- A Claims Database And Data Mining Analysis

    May 1, 2015, 00:00

  • Valuing Survival Gains In Myelodysplastic Syndromes Attributable To Novel Cancer Therapies

    May 1, 2015, 00:00

  • Invariance of Quality of Life Questionnaire Eortc Qlqc30 In Different Cancer Indications

    May 1, 2015, 00:00

  • Agents Acting On Renin-Angiotensin System Usage In Croatia During The Fourteen-Year Period- Impact Of Generics

    May 1, 2015, 00:00

  • Direct costs comparison of medical care before and after Heart failure Hospitalization in a Medicare Population

    May 1, 2015, 00:00

  • Depression And Quality Of Life Among Individuals With Chronic Obstructive Pulmonary Disease In North India

    May 1, 2015, 00:00

  • Assessment of the Costs and outcomes of Antiretroviral Therapy In Adult Outpatients at a Tertiary Hospital In Harare, Zimbabwe

    May 1, 2015, 00:00

  • Analysis of Health Technology assessment requirements in 7 Asia Oceania Countries/regions- comparison of evidentiary requirements for standard and Orphan Drugs

    May 1, 2015, 00:00

  • Choosing between the promis global and eq-5d for comparative effectiveness research- are they really different?

    May 1, 2015, 00:00

  • Patient-reported outcome measures for Multiple Sclerosis Phase Iv Clinical Trials- A Systematic Review

    May 1, 2015, 00:00

  • Patient Preference for Real-Time Feedback In Epro Assessments for Copd Clinical Trials

    May 1, 2015, 00:00

  • Patients’ Groups And Advocacy In Oncology- Awareness, Support And Unmet Needs

    May 1, 2015, 00:00

  • Will U.S. payers Champion Biosimilars?

    May 1, 2015, 00:00

  • Predictors of Glycemic Control and diabetes-related costs among adult type 2 Diabetes Patients Initiating Therapy with Liraglutide

    May 1, 2015, 00:00

  • Impact of post-surgical complications on Hospital costs and Margins

    May 1, 2015, 00:00

  • Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data

    May 1, 2015, 00:00

  • Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee

    May 1, 2015, 00:00

  • Cost of Adminstration of a Single dose of Rotavirus Vaccine in Canada

    May 1, 2015, 00:00

  • Potential savings in Healthcare spending on “low-value” interventions- case study of Arthroscopic Knee Surgery

    May 1, 2015, 00:00

  • Comparative outcomes of Testosterone therapy versus no Treatment in hypogonadic men

    May 1, 2015, 00:00

  • Evaluating The Outcomes of A Diabetes Treatment Management Program Targeting Appropriate Anti-Hypertensive Treatment For Adults With Diabetes for Dual And Non-Dual Eligible Medicare Advantage Beneficiaries

    May 1, 2015, 00:00

  • Trends In Use Of Health Economic Evidence For Developing Clinical Guidelines

    May 1, 2015, 00:00

  • Cost implication of using Lorcaserin in Weight Management prior to Bariatric Surgery

    May 1, 2015, 00:00

  • Physician’s Adherence To Treatment Guidelines In Deep Vein Thrombosis At An Indian Tertiary Healthcare Facility

    May 1, 2015, 00:00

  • Impact of New changes due to Affordable care act on US Market Access

    May 1, 2015, 00:00

  • Barriers to Treatment Adherence associated with acromegaly In the united states- Provider’s Perspective

    May 1, 2015, 00:00

  • What factors make Economic Evaluation more valuable as a service?

    May 1, 2015, 00:00

  • WITHDRAWN

    May 1, 2015, 00:00

  • Systematic Review of Epidemiology and Burden of Pancreatic Cancer

    May 1, 2015, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Adults In The Philippines Its Clinical and Policy Implications in the Case Rate Payments of The Philippine Health Insurance Corporation

    May 1, 2015, 00:00

  • Is visual impairement associated with increased Hospitalization? a retrospective Cohort study of community-dwelling medicare beneficiares

    May 1, 2015, 00:00

  • Burden of Disease and Economic Impact of Malaria In Colombia, 2012

    May 1, 2015, 00:00

  • Cross section analysis of Marginal NHS expenditure by England Health area

    May 1, 2015, 00:00

  • Cost-Benefit Analysis Of Whole Body Bone Scintigraphy In The Pre-Transplant Assessment Of Adult Patients, Bearers Of Hepatocellular Carcinoma, In A Liver Transplant Waiting List, From Dead Donors, In A Reference Hospital In The South Of Bra ...

    May 1, 2015, 00:00

  • Cost-effectiveness of Ikervis® in severe dry Eye disease in the UK

    May 1, 2015, 00:00

  • Comparative efficacy and Safety of Antidiabetic Drug Regimens Added to Stable and Inadequate metformin and thiazolidinedione therapy In type 2 diabetes

    May 1, 2015, 00:00

  • Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients- Computer Assisted Qualitative Data Analysis (Caqdas) Of An Expert Panel

    May 1, 2015, 00:00

  • Development And Validation Of The Promis Network To Evaluate Patient-Reported Health Status Associated With Clostridium Difficile Infection

    May 1, 2015, 00:00

  • Decreasing Ebm order Set review and approval cycle time

    May 1, 2015, 00:00

  • Estimation of direct healthcare costs of gynecologic cancer in the u.s.- an analysis of 2007-2011 medical expenditure panel survey (meps) data

    May 1, 2015, 00:00

  • Cost-effectiveness of AQP4 antibody detection with cell-based assay compared with elisa for devic disease Diagnosis in Colombia

    May 1, 2015, 00:00

  • Depression Treatment and Health-Related quality of Life among adults with Diabetes and depression

    May 1, 2015, 00:00

  • HIV Antiretroviral drug utilization and Expenditures In Medicaid 1991-2014

    May 1, 2015, 00:00

  • Risk of Glucocorticoid-related adverse events in Patients with Systemic Lupus Erythematous- findings from a 12-year Longitudinal follow-up study in Taiwan

    May 1, 2015, 00:00

  • Antimicrobial Utilisation in Slovak Hospitals

    May 1, 2015, 00:00

  • Patient Reported outcome Profiles of Adults receiving medical care at Specialty Clinics for chronic pain and diabetes

    May 1, 2015, 00:00

  • The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience

    May 1, 2015, 00:00

  • Trajectories of Buprenorphine treatment and Associated Emergency Department and inpatient use in a large Medicaid Program

    May 1, 2015, 00:00

  • Getting The Full Picture- The Importance Of Exrapolating Beyond The Data

    May 1, 2015, 00:00

  • Real World data for Health and Technology assessment in Brazil- an unmet need

    May 1, 2015, 00:00

  • Comparison of the impact of Human versus analogue insulins on Glycosylated Hemoglobin in a Population with Diabetes Mellitus Colombia

    May 1, 2015, 00:00

  • Lessons learned from the Pilot introduction of Peginesatide, a Third generation Erythropoiesis Stimulating Agent

    May 1, 2015, 00:00

  • The Impact of Endoscopic Linear Stapling Device Stability in Thoracic Surgery- a Delphi Panel Approach

    May 1, 2015, 00:00

  • TUBERCULOSIS screening preferences of Healthcare workers in South Africa- a best-worst scaling study to analyze variation by Occupation

    May 1, 2015, 00:00

  • Lack of Adherence to Immunosuppressive Treatment In Kidney Transplant Patients- Estimation of Associated Direct Medical Costs

    May 1, 2015, 00:00

  • A Cost-effectiveness Analysis of A biomarker Test Compared to Standard of Care Surveillance in Patients With Barrett’s Esophagus

    May 1, 2015, 00:00

  • Prevalence And Predictor Of Antidepressants Use During Pregnancy In The Us- An Nhanes Study

    May 1, 2015, 00:00

  • Medicare beneficiary out-of-pocket spending for stroke prevention in non-valvular Atrial Fibrillation- a budget analysis

    May 1, 2015, 00:00

  • Correlation between Pain Catastrophizing scale and disease characteristics in Chronic Low Back Pain Patients

    May 1, 2015, 00:00

  • Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

    May 1, 2015, 00:00

  • The Impact of Different Types of Health Insurance on The Hospitalization Services Utilization of Patients With Hemorrhagic Stroke In China

    May 1, 2015, 00:00

  • Relative Efficacy and Tolerability of Vortioxetine versus Approved Antidepressants for Major depressive Disorder- a meta-regression of Clinical Trials

    May 1, 2015, 00:00

  • Evaluating Content Validity Of Performance Outcomes (Perfos)- Establishing The Patient-Relevance Of Three Perfos In Elective Total Hip Replacement (Ethr)

    May 1, 2015, 00:00

  • Important Statistical Considerations For Developing Equations For Disease Simulators

    May 1, 2015, 00:00

  • Safety of Tofacitinib Compared to Biological Dmards In Rheumatoid Arthritis Patients With An Inadequate Response to Methotrexate- overview of Systematic Reviews

    May 1, 2015, 00:00

  • Skeletal Muscle activity and Resource tool for sporadic Inclusion body Myositis (Smart-Sibm)- Characterization of Resource Utilization and Financial Burden Experienced By Sibm Patients

    May 1, 2015, 00:00

  • Estimating the cost-effectiveness of left Atrial Appendage closure compared to warfarin for stroke prevention in Atrial Fibrillation

    May 1, 2015, 00:00

  • Pneumococcal vaccination Coverage In adults with high-risk Conditions- Missed Opportunities Continue

    May 1, 2015, 00:00

  • A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)

    May 1, 2015, 00:00

  • Quality-of-Life Predictors of Treatment Continuation on Eslicarbazepine acetate monotherapy Among subjects with refractory Partial-Onset Seizures

    May 1, 2015, 00:00

  • Outpatient Follow-Up Visits After Hospital Discharge for Mental Illness and Implications for re-admissions

    May 1, 2015, 00:00

  • Preferences for New Treatments Diminish In The Face of Ambiguity

    May 1, 2015, 00:00

  • Cost Effectiveness of Apixaban For Stroke Prevention In Non Valvular Atrial Fibrillation In The Ecuatorian Public Healthcare Sector

    May 1, 2015, 00:00

  • Physician perception of Pharmacy adherence barriers in a Cohort of Medicare advantage plans in Texas

    May 1, 2015, 00:00

  • Change in Healthcare Utilization and costs in Patients with Major Depressive Disorder (MDD) initiating adjunctive Therapy with Second-Generation Antipsychotics (SGAS)

    May 1, 2015, 00:00

  • Biologic Adherence among Psoriasis Patients in the us Medicare Population

    May 1, 2015, 00:00

  • HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEA

    May 1, 2015, 00:00

  • Review Of Methodological Approaches To Generate Propensity Scores In Multilevel Data

    May 1, 2015, 00:00

  • Formulary Management Of Branded Drugs With And Without Boxed Warnings Within Therapeutic Categories

    May 1, 2015, 00:00

  • Rate of adverse event-related treatment changes and Healthcare costs associated with topical Rosacea treatment

    May 1, 2015, 00:00

  • Impact of Medicaid managed care expansion on access to providers in Mississippi

    May 1, 2015, 00:00

  • Cost effectiveness of Levodopa/Carbidopa Intestinal Gel In Ireland

    May 1, 2015, 00:00

  • Direct and indirect costs to Employers of recall following screening Mammography among Female Employees in the us

    May 1, 2015, 00:00

  • Economic value of preventing central venous catheter sepsis infections with early cannulaton arteriovenous grafts (ECAVGS) compared to Non-Ecavgs

    May 1, 2015, 00:00

  • Communicating risk of Medication side effects- how rare is ‘rare’ and how likely is ‘likely’?

    May 1, 2015, 00:00

  • Economic Impact of Avoidable Drug Wastage In Patients Admitted to the Hospital for An Acute Copd Exacerbation

    May 1, 2015, 00:00

  • The 5 principal causes of death in mexico in the last 5 years, is the public health system covering these needs?

    May 1, 2015, 00:00

  • A System dynamics model for the cost-effectiveness evaluation of Bacterial whole-genome sequencing for detecting and monitoring outbreaks of MRSA

    May 1, 2015, 00:00

  • Evaluation Of Matching-Adjusted Indirect Comparison Implemented By A Resampling Method

    May 1, 2015, 00:00

  • Use of prescription monitoring programs by Primary Care Physicians- results of a National Survey

    May 1, 2015, 00:00

  • Adherence to Iron Chelation Therapy and associated Healthcare resource Utilization and costs in Medicaid Patients with Thalassemia

    May 1, 2015, 00:00

  • Suggestion Of New Methods To Calculate Confidence Interval For Incremental Cost-Effectiveness Ratio Which Solve The Issues With Conventional Method

    May 1, 2015, 00:00

  • Economic burden of vaccine-preventable diseases among the elderly in Taiwan

    May 1, 2015, 00:00

  • Comparison of ultra Orphan and Cancer Drug pricing in the US and the UK

    May 1, 2015, 00:00

  • Predicting medical reimbursement amount - what factors drive the medical cost trend

    May 1, 2015, 00:00

  • Differences in Breast Cancer screening rates in medicare advantage non-dual eligible members, dual eligibles enrolled in special need plans and other Healthcare Plans

    May 1, 2015, 00:00

  • A Comparative Cost Utility Analysis For First Line Treatment Of Metastatic Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Exon 19 Deletions Or Exon 21 (L858r) Substitution Mutations

    May 1, 2015, 00:00

  • Adherence to Tamoxifen and Armoatase Inhibitors Among Women Enrolled In Medicaid Program

    May 1, 2015, 00:00

  • Comparing total and disease specific Healthcare costs for Glaucoma Patients before and after their index Diagnosis- a retrospective claims database analysis

    May 1, 2015, 00:00

  • Is there utility in clinical utility modeling for Diagnostic Technologies?

    May 1, 2015, 00:00

  • Pharmacotherapeutic and Economic indicators of the use of Immunobiologicals Drugs- analysis of a Rheumatic Patient Cohort

    May 1, 2015, 00:00

  • Assessing The Relative Contribution To Changes In Quality-Adjusted Life Expectancy Associated With Hba1c, Weight And Hypoglycaemia Across Multiple Risk Equations With The Core Diabetes Model (Cdm)

    May 1, 2015, 00:00

  • Inpatient Versus Outpatient Treatment Related to Exacerbation Episodes In Chronic Obstructive Pulmonary Disease (Copd) From A Public Mexican Institutional Perspective)

    May 1, 2015, 00:00

  • Drug Use Among Seniors On Public Drug Programs In Canada, 2012

    May 1, 2015, 00:00

  • Exploring Heterogeneity In Attribute Processing Strategies- Use Of Hybrid Random Utility Maximization-Random Regret Minimization (Rum-Rrm) Models In A Discrete Choice Experiment (Dce)

    May 1, 2015, 00:00

  • The Impact of Emotional And Social Support on The Quality of Life, Depression, And Disability Among Us Adults With Chronic Obstructive Pulmonary Disorder (Copd)- A Propensity Score Analysis

    May 1, 2015, 00:00

  • Does oral cholecalciferol supplementation improves pain intensity and disability in patients with chronic low back pain?

    May 1, 2015, 00:00

  • Directly Eliciting Personal Utility Functions- A New Way To Value Health-Related Quality Of Life

    May 1, 2015, 00:00

  • Identifying Key factors for Targeting Patients most suitable for Community Health Worker program

    May 1, 2015, 00:00

  • The Burden of Gout in a Canadian Primary Care Population

    May 1, 2015, 00:00

  • Budget Impact Analysis of Botulinum Toxin A Therapy For Upper Limb Spasticity In Hong Kong

    May 1, 2015, 00:00

  • Medication use survey of inpatients with basic Medical Insurance from 2010 to 2012

    May 1, 2015, 00:00

  • A Review of Clinical outcome Assessments used in FDA approved Drug labels for Mental Health conditions

    May 1, 2015, 00:00

  • Current estimates of the Public Pharmaceutical expenditure in Mongolia

    May 1, 2015, 00:00

  • THE BUDGET IMPACT OF DUORESP® SPIROMAX® (BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) COMPARED WITH COMMONLY PRESCRIBED DRY POWDER INHALERS FOR THE MANAGEMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED KINGDOM- IMPACT ...

    May 1, 2015, 00:00

  • Comparing The Adoption Of Epro In Clinical Research To Emr In Clinical Practice – Why Clinical Practice Is Ahead Of Research With Technology Use

    May 1, 2015, 00:00

  • Linezolid Prescription Pattern- Identifying the use to Rationalize The Practice

    May 1, 2015, 00:00

  • Time And Motion Study For Rituximab Sc Vs Iv In Colombian Patients With Non-Hodgkin Lymphoma

    May 1, 2015, 00:00

  • Patients’ And Physicians’ Time Trade-Off Preferences For Adverse Outcomes Associated With Metastatic Colorectal Cancer Treatments

    May 1, 2015, 00:00

  • Economic Analysis of Biologic Alternatives In The Management of Rheumatoid Arthritis, Psoriasis and ankylosing Spondylitis From Public and Private Perspectives in Brazil

    May 1, 2015, 00:00

  • Impact of non-medical switching on Healthcare costs- a claims database analysis

    May 1, 2015, 00:00

  • Signs, Symptoms, and Existing Patient-Reported outcome (Pro) Measures In Hospital-Acquired Bacterial Pneumonia (Habp)- A Comprehensive Literature Review

    May 1, 2015, 00:00

  • Cost Effectiveness of Tofacitinib as Second Line Treatment vs Using Biological Therapies In The Treatment of Moderate Rheumatoid arthritis after Failure of dmards In Panama In 2014

    May 1, 2015, 00:00

  • Economics Of Diabetes Mellitus- Theory And Evidence For Brazilian Data In 2008

    May 1, 2015, 00:00

  • Impact of Surgical Site Infections following common Ambulatory Procedures on Healthcare Costs

    May 1, 2015, 00:00

  • Economic Analysis of Empiric Versus Diagnostic-Driven Strategies for Immunocompromised Patients With Suspected Aspergillus Invasive Fungal Infections In China

    May 1, 2015, 00:00

  • Developing Sf-6d-V2- Examining The Dimensionality Of The Sf-36 Using Large Multinational Datasets

    May 1, 2015, 00:00

  • Public Perspectives On Cost-Related Non-Adherence Among Patients

    May 1, 2015, 00:00

  • Impact of Medication Therapy Management (MTM) pilot program on Healthcare Utilization and costs among Texas medicaid patients with Hypertension

    May 1, 2015, 00:00

  • Are biomarkers a big market access bonus? us and eu5 payer perspectives and prescribing patterns for key targeted non-small-cell lung cancer agents

    May 1, 2015, 00:00

  • Association of Hepatitis C Virus infection with risk of Chronic Kidney Disease- systematic review and meta-analysis

    May 1, 2015, 00:00

  • Universal screening identifies higher Thyroid Dysfunction in pregnancy. evidence based meta-analysis

    May 1, 2015, 00:00

  • The Burden Of Uncertainty In Emergency Room- The Case Of Chest Pain

    May 1, 2015, 00:00

  • Estimating Utility values for Polycythemia vera using patient-reported outcomes from the response trial and existing Mapping Algorithms

    May 1, 2015, 00:00

  • Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation

    May 1, 2015, 00:00

  • Evaluating The Economic Implications of Nonadherence And Antibody-Mediated Rejection In Renal Transplant Recipients- The Role of Once-Daily, Prolonged-Release Tacrolimus In The Uk Setting

    May 1, 2015, 00:00

  • Demonstrating the cost effectiveness of Movantik for the treatment of opioid induced constipation in Patients with inadequate response to Laxatives; a UK perspective

    May 1, 2015, 00:00

  • Clinical and budget impact of using a test to Detect Kras mutations in Metastatic Colorectal Cancer patients in the United States

    May 1, 2015, 00:00

  • Comparing The Eq-5d-3l And Sf-6d Utility Scores Of Acute Coronary Syndrome Patients From An Asian Population

    May 1, 2015, 00:00

  • Depression treatment patterns among individuals with Chronic Obstructive Pulmonary disease

    May 1, 2015, 00:00

  • When The Literal Meaning Just Won’t Do - Cultural Adaptation Issues Resolved During The Linguistic Validation Of A Behavioural Scale

    May 1, 2015, 00:00

  • Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan

    May 1, 2015, 00:00

  • Measurement of Health State Utilities For Relapsed or Refractory Peripheral T-Cell Lymphoma By using time trade-off And Visual Analog Scale Method

    May 1, 2015, 00:00

  • Effects of Autologous fat grafting systems on inpatient operating room time and costs- a Hospital budget impact analysis

    May 1, 2015, 00:00

  • Oral disease modifying therapy for multiple sclerosis; is this the new normal?

    May 1, 2015, 00:00

  • The Use of Heliox in Hospitalized Children From Cartagena Colombia

    May 1, 2015, 00:00

  • Past trends and current challenges in the hepatitis c reimbursement landscape- is history repeating itself?

    May 1, 2015, 00:00

  • Patient-Reported Outcomes (Pros) In Bladder Cancer

    May 1, 2015, 00:00

  • Utilizing Electronic Medical Record Networks For Identifying Patients For Clinical Trial Recruitment

    May 1, 2015, 00:00

  • Augmenting The Regulatory Requirements Of Medication Therapy Management To Improve Program Efficiency And Outcomes

    May 1, 2015, 00:00

  • Patients sent to the emergency department by advanced healthcare providers are more likely to need admission

    May 1, 2015, 00:00

  • Antihypertensive Drug Utilization In Elderly Outpatients In Serbia

    May 1, 2015, 00:00

  • Quality of evidence supporting inclusion of Pharmacogenomic biomarkers in product labels of fda approved Oncology Therapies

    May 1, 2015, 00:00

  • Reducing And Quantifying Over-Fitting In Regression Models

    May 1, 2015, 00:00

  • Remote monitoring strategies for patients with stable Heart failure- a systematic review and Network meta-analysis

    May 1, 2015, 00:00

  • Economic implications of increasing usage of Calcium-Free balanced crystalloid solutions (BAL) versus 0.9% saline for intravenous (IV) fluid Therapy in patients with Systemic Inflammatory Response Syndrome (SIRS) in us Hospitals

    May 1, 2015, 00:00

  • Identification and Characterization of Long Term Survival Population In Non-Small-Cell Lung Cancer Patients Treated With Immunotherapies

    May 1, 2015, 00:00

  • Analysis Of Nice Drug Technology Appraisals (2001-September 2014)

    May 1, 2015, 00:00

  • The impact of alternative Antipsychotic Medications on the risk of adverse events in patients treated for Schizophrenia

    May 1, 2015, 00:00

  • Real-World Outcomes of Acute Ischemic Stroke Patients In The Medicare Population

    May 1, 2015, 00:00

  • DEVELOPMENT, VALIDATION, AND ANALYSIS OF A LINEAR REGRESSION MODEL PREDICTING CHILD’S BIRTHWEIGHT FROM MOTHER’S RACE, EDUCATION LEVEL, SMOKING STATUS, AND GESTATION AGE

    May 1, 2015, 00:00

  • Detemir in Diabetes type 2 Patients a cost-utility analysis, colombia 2014

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Meniscal Repair Versus Partial Meniscectomy- A Model-Based Projection of Clinical Outcomes And Costs In The United States Healthcare System

    May 1, 2015, 00:00

  • Analysis of Adverse Drug Reactions During Pharmacotherapeutic Follow-Up of Hiv+ Patients

    May 1, 2015, 00:00

  • Evaluation Of Medication Adherence Rate Among Hemodialysis Patients- A Multicentric Comparative Study

    May 1, 2015, 00:00

  • The Californian Technology assessment forum – the arrival of cost-utility appraisals of Drugs in the USA?

    May 1, 2015, 00:00

  • Study of Patient Related outcomes of Type 2 Diabetes and Comparative analysis of pioglitazone sales pre and post ban in Mumbai,India

    May 1, 2015, 00:00

  • Treatment of acute Appendicitis in Germany- results of the analysis of a Health Insurance claims database

    May 1, 2015, 00:00

  • Assessing a Physician visit for Hepatic Dysfunction based on database merging claims and Annual Health Checkup data in Japan

    May 1, 2015, 00:00

  • The Burden of Aml Within the

    May 1, 2015, 00:00

  • Use of Health belief model to understand Knowledge, Attitudes And Behaviors of People Towards The Ebola outbreak

    May 1, 2015, 00:00

  • An Innovative Cloud-Based Platform for Implementing Performance-Based Risk-Sharing Arrangements (Pbrsas) in Oncology Settings

    May 1, 2015, 00:00

  • The Value Women Place On Menopausal Symptom Relief

    May 1, 2015, 00:00

  • The rise of the value analysis committee at Us Hospitals, better or worse for medical device companies?

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions In Japan Using The Discrete Event Simulation Model

    May 1, 2015, 00:00

  • Analysis Of Treatment Cost For Uterine Fibroids In Ukraine

    May 1, 2015, 00:00

  • Economic Impact of The Addition of Axitinib as a Second Line Treatment for Metastatic Renal cell Carcinoma in the Ecuatorian Public Heathcare Sector

    May 1, 2015, 00:00

  • Japan Pricing Methodology Analogue Assessment

    May 1, 2015, 00:00

  • Direct Medical Cost Comparison Between Patients Receiving Cangrelor And Clopidogrel During Percutaneous Coronary Intervention- Champion Phoenix Economic Sub-Study Results

    May 1, 2015, 00:00

  • Estimating Clinical and Economic Outcomes Following a Diabetes-Related vascular Complication

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Anidulafungin In the treatment of Candidemia In Chile

    May 1, 2015, 00:00

  • Healthcare resource use among Patients with congestive Heart failure in a Large Health Organization

    May 1, 2015, 00:00

  • Factors Affecting Immunization Timeliness In Malaysia

    May 1, 2015, 00:00

  • Effectiveness And Cost-Effectiveness Of Catheter-Directed Thrombolysis In Massive Pulmonary Embolism

    May 1, 2015, 00:00

  • Allogeneic peripheral blood versus bone marrow hematopoietic cell transplantation from unrelated donors- a meta-analysis

    May 1, 2015, 00:00

  • Anticholinergic Medication use and risk of incident Fractures in the elderly with Depression

    May 1, 2015, 00:00

  • A Comparison of G-BA’s additional benefit score to NICE ICERs

    May 1, 2015, 00:00

  • Prevalence of Medication use not captured by prescription claims databases – an analysis using 2012 Medical Expenditure Panel Survey Data

    May 1, 2015, 00:00

  • Measuring Disease specific impact and symptoms among patients with Hidradenitis Suppurativa

    May 1, 2015, 00:00

  • Estimating the cost-Effectiveness of 12 weeks of treatment with Daclatasvir+Sofosbuvir In Patients Chronically Infected With hcv Genotype 3

    May 1, 2015, 00:00

  • Real-World Practice Patterns For The Treatment Of Complicated Skin And Skin Structure Infections In Europe- A Retrospective Database Analysis

    May 1, 2015, 00:00

  • Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple Sclerosis

    May 1, 2015, 00:00

  • Cost-Utility Evaluation Of Continuing Education For The Management Of Type 2 Diabetes Mellitus Users In Pernambuco – Brazil

    May 1, 2015, 00:00

  • Development and validation of a u.s. Administrative claims-based algorithm to classify patients with type 2 diabetes mellitus into renal impairment stages

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Cellular/Tissue derived products for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • Determining patterns of Opioid misuse and misprescribing in South Carolina

    May 1, 2015, 00:00

  • Performance of two World Health Organization Dengue classifications in a Pediatric Cohort from Colombia

    May 1, 2015, 00:00

  • Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness

    May 1, 2015, 00:00

  • Validation And Valuation Of The Preference-Based Healthindex Using Eq-5d-5l In The Hong Kong Population

    May 1, 2015, 00:00

  • Assessment Of Drug Utilization Pattern And Clinical Outcome In Pregnancy Induced Hypertension In Teritary Care Hospital

    May 1, 2015, 00:00
  • «
  • 91
  • 92 (current)
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »